these encouraging preliminary data suggest that ganciclovir therapy should be started as soon as cytomegalovirus infection is suspected , especially in cytomegalovirus seronegative recipients receiving a seropositive graft .
C0017066
ganciclovir
C0010823
cytomegalovirus infection